Jinhai Med Tech (02225.HK): Appoints Ma Chengdong as Chief Marketing Officer to Accelerate Foray into Neurosurgical Endoscopy Sector

NewTimeSpace · 2026/08/03 18:20 · By Zeyu Wu

NewTimeSpace News: Jinhai Medical Technology Limited (02225.HK) announced that Mr. Ma Chengdong has been appointed as the Group’s Chief Marketing Officer, effective 3 August 2026. He will mainly be responsible for product marketing strategies, market access, academic promotion, sales and channel operation of the Group. Graduated from Shanghai Medical University, Mr. Ma boasts over 25 years of experience in marketing and sales management at international medical enterprises including GE Healthcare China and Medtronic China.

NewTimeSpace News: Jinhai Medical Technology Limited issued a voluntary announcement on 3 August 2026. Mr. Ma Chengdong has been appointed as the Group’s Chief Marketing Officer with effect from 3 August 2026 for an initial term of one year. Mr. Ma will take charge of the Group’s product marketing strategies, market access, academic promotion, sales and channel operation, and oversee the commercialization of medical devices and equipment.

Aged 55, Mr. Ma graduated from Shanghai Medical University (now known as Shanghai Medical College, Fudan University), majoring in Clinical Medicine, and completed a five-year residency training at Shanghai Institute of Cardiovascular Diseases. In his career spanning over 25 years, he worked at GE Healthcare (China) Co., Limited and held various posts including Technical Manager, Product Manager, Regional Sales Director, Greater China Marketing Manager and General Manager of Clinical Application and Research Team. He also served Medtronic (Shanghai) Management Co., Limited as Senior Director of CSOT Strategic Marketing and Senior Director of Commercial Operational Excellence.

The Board believes that as the healthcare industry in Mainland China develops towards intelligence, minimally invasive treatment, domestic substitution and integration of cutting-edge technologies, the Group is well-positioned to enter the neurosurgical endoscopy sector with its strengths in minimally invasive surgical solutions. The appointment of Mr. Ma will further enhance the Group’s marketing and promotion capabilities in minimally invasive and non-invasive treatment fields.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

JINHAI MED TECH 02225.HK Chief Marketing Officer